In addition, we detected that the serum concentrations of DC-SIGNR were significantly higher in colon cancer patients with liver metastasis (94.81 ± 44.99 ng/ml) than in patients without metastasis (67.20 ± 29.67 ng/ml) (P = 0.0258) (Fig. 6b). The gene discussed is CLEC4M; the disease is colonic neoplasm.